Search research articles
Contact Us
Filters
Showing results (21-30 of 44) with videos related to
Page
of 5
Sort By:
Molecular & Cellular Proteomics : MCP
|
March 2, 2013
Translational predictive biomarker analysis of the phase 1b sorafenib and bevacizumab study expansion cohort
Nilofer Azad, Minshu Yu, Ben Davidson, et al.
Elife
|
May 20, 2025
ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1
Jordina Rincon-Torroella, Marco Dal Molin, Brian Mog, et al.
Investigational New Drugs
|
May 23, 2012
Phase I pharmacokinetic and pharmacodynamic study of cetuximab, irinotecan and sorafenib in advanced colorectal cancer
Nilofer Azad, Arvind Dasari, John Arcaroli, et al.
Journal of the National Cancer Institute
|
May 21, 2014
Phase I/Ib study of olaparib and carboplatin in BRCA1 or BRCA2 mutation-associated breast or ovarian cancer with biomarker analyses
Jung-Min Lee, John L Hays, Christina M Annunziata, et al.
Journal of the American College of Radiology : JACR
|
March 6, 2016
ACR Appropriateness Criteria Radiologic Management of Hepatic Malignancy
Brian E Kouri, Ross A Abrams, Waddah B Al-Refaie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 17, 2022
Somatic Genomic Testing in Patients With Metastatic or Advanced Cancer: ASCO Provisional Clinical Opinion
Debyani Chakravarty, Amber Johnson, Jeffrey Sklar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 12, 2018
A Phase I Trial of a Guadecitabine (SGI-110) and Irinotecan in Metastatic Colorectal Cancer Patients Previously Exposed to Irinotecan
Valerie Lee, Judy Wang, Marianna Zahurak, et al.
International Journal of Surgical Oncology
|
August 31, 2012
Intensity-modulated radiation therapy for rectal carcinoma can reduce treatment breaks and emergency department visits
Salma K Jabbour, Shyamal Patel, Joseph M Herman, et al.
American Journal of Clinical Oncology
|
February 24, 2017
ACR Appropriateness Criteria® Resectable Pancreatic Cancer
William E Jones, W Waren Suh, May Abdel-Wahab, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 25, 2019
Executive Summary of the American Radium Society Appropriate Use Criteria for Local Excision in Rectal Cancer
Suzanne Russo, Christopher J Anker, May Abdel-Wahab, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 44) with videos related to
Sort By:
Page
of 5
Molecular & Cellular Proteomics : MCP
|
March 2, 2013
Translational predictive biomarker analysis of the phase 1b sorafenib and bevacizumab study expansion cohort
Nilofer Azad, Minshu Yu, Ben Davidson, et al.
Elife
|
May 20, 2025
ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1
Jordina Rincon-Torroella, Marco Dal Molin, Brian Mog, et al.
Investigational New Drugs
|
May 23, 2012
Phase I pharmacokinetic and pharmacodynamic study of cetuximab, irinotecan and sorafenib in advanced colorectal cancer
Nilofer Azad, Arvind Dasari, John Arcaroli, et al.
Journal of the National Cancer Institute
|
May 21, 2014
Phase I/Ib study of olaparib and carboplatin in BRCA1 or BRCA2 mutation-associated breast or ovarian cancer with biomarker analyses
Jung-Min Lee, John L Hays, Christina M Annunziata, et al.
Journal of the American College of Radiology : JACR
|
March 6, 2016
ACR Appropriateness Criteria Radiologic Management of Hepatic Malignancy
Brian E Kouri, Ross A Abrams, Waddah B Al-Refaie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 17, 2022
Somatic Genomic Testing in Patients With Metastatic or Advanced Cancer: ASCO Provisional Clinical Opinion
Debyani Chakravarty, Amber Johnson, Jeffrey Sklar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 12, 2018
A Phase I Trial of a Guadecitabine (SGI-110) and Irinotecan in Metastatic Colorectal Cancer Patients Previously Exposed to Irinotecan
Valerie Lee, Judy Wang, Marianna Zahurak, et al.
International Journal of Surgical Oncology
|
August 31, 2012
Intensity-modulated radiation therapy for rectal carcinoma can reduce treatment breaks and emergency department visits
Salma K Jabbour, Shyamal Patel, Joseph M Herman, et al.
American Journal of Clinical Oncology
|
February 24, 2017
ACR Appropriateness Criteria® Resectable Pancreatic Cancer
William E Jones, W Waren Suh, May Abdel-Wahab, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 25, 2019
Executive Summary of the American Radium Society Appropriate Use Criteria for Local Excision in Rectal Cancer
Suzanne Russo, Christopher J Anker, May Abdel-Wahab, et al.
Page
of 5